Acetyl Glutathione (S-Acetyl Glutathione).

Cysteine is the limiting building block the body uses to make glutathione, and NAC delivers that cysteine. Pairing it with acetyl glutathione supplies both the finished molecule and the raw material the body draws on to keep its own pool topped up.

Alpha lipoic acid, once reduced in the cell, returns oxidized glutathione to its active reduced form, so the antioxidant can be used again rather than spent once. The two sit in the same cellular recycling loop that keeps redox balance steady.

Glutathione does much of its antioxidant work through glutathione peroxidase, and selenium is the mineral built into that enzyme's active site. Adequate selenium lets the glutathione the body carries actually neutralize peroxides.

Vitamin C and glutathione help regenerate each other within the cell's antioxidant network, each helping restore the other after it has quenched a reactive molecule. Together they extend how long the shared pool stays in its active state.

Glutathione is a tripeptide of glutamate, cysteine and glycine, and glycine availability sets the rate of the second synthesis step. Supplying it supports endogenous production alongside a preformed dose.

Cysteine is the limiting amino acid for glutathione synthesis because its thiol carries the redox activity. Raising cysteine supply raises endogenous production.

Glutamine converts to glutamate, the third residue of the tripeptide and the substrate for glutamate cysteine ligase. It keeps the first synthesis step supplied.

Glutathione reductase is an FAD enzyme and FAD comes from riboflavin. Without it, oxidised glutathione is not returned to its reduced form.

Glutathione reductase spends NADPH on every recycling turn, and the nucleotide is built from niacin. Niacin status is one input to how fast glutathione is regenerated.

Cystathionine beta-synthase and cystathionine gamma-lyase both need pyridoxal phosphate to turn homocysteine into cysteine. That is the main route by which the body makes its own glutathione substrate.

Glutathione sits at the end of the chain that regenerates ascorbate, which in turn regenerates tocopherol in the membrane. The three form one linked recycling system.

Sulforaphane activates Nrf2, which raises transcription of glutamate cysteine ligase and glutathione reductase. It increases the machinery while a direct dose supplies the molecule.

Broccoli sprout glucoraphanin converts to sulforaphane, which raises expression of the enzymes that build and recycle glutathione.

SAM-e sits in the methionine cycle that hands homocysteine to the transsulfuration pathway and on to cysteine, the precursor route to glutathione.

Betaine remethylates homocysteine back to methionine, which changes how much homocysteine is left for the transsulfuration route to cysteine. Both act on the same sulfur amino acid pool.

Glutathione synthesis is limited by cysteine availability, and whey protein is unusually rich in cysteine, much of it as cystine in beta-lactoglobulin and in the glutamylcysteine dipeptide fraction. Feeding cysteine as part of a protein rather than free means it arrives with the glutamate and glycine the ligase and synthetase also need. The precursor logic is settled; what whey trials measure is blood or tissue glutathione, a marker.

Cysteine leaving transsulfuration is divided between glutathione synthesis, taurine synthesis via cysteine dioxygenase, and sulfate. Supplying taurine directly means less cysteine has to be diverted down that branch. It is a competing-demand relationship described by established pathway biochemistry rather than a measured combination.

The end of cysteine catabolism runs through sulfite, and sulfite oxidase, which converts it to sulfate for excretion, is a molybdenum cofactor enzyme. Anything that increases sulfur amino acid throughput increases traffic through that step. Textbook cofactor dependence, sitting downstream of glutathione turnover rather than in the synthesis itself.

Folate status determines how much homocysteine is remethylated to methionine versus committed to the transsulfuration route that produces cysteine, the rate-limiting glutathione precursor. Where folate is limiting, the partition shifts. This is established one-carbon wiring and the way to read it is as flux, not as an effect of folate on glutathione.

Methionine synthase needs methylcobalamin to recycle homocysteine, so B12 status is one of the two levers setting how much homocysteine goes to cysteine instead. That cysteine is what glutathione synthesis draws on. Established pathway relationship; homocysteine itself is a marker of the partition, not an outcome.

Silymarin flavonolignans induce the Nrf2-driven antioxidant response element, and the catalytic and modifier subunits of glutamate-cysteine ligase are among the genes it controls. Raising enzyme expression and supplying substrate act at different points in the same pathway. The Nrf2 induction is well described in cell and animal work; the combination itself has not been measured in people.

EGCG shifts Nrf2 into the nucleus and raises expression of glutamate-cysteine ligase and other antioxidant response genes in cell systems. At higher concentrations the same catechol chemistry can generate hydrogen peroxide and consume glutathione, so the direction depends on dose. Both arms of that are laboratory observations, which is why this row stays page-only.

Oxidised quercetin forms quinone and semiquinone species that are conjugated by glutathione, which both detoxifies them and consumes reduced glutathione. Supplying the tripeptide addresses the same pool the flavonoid draws on. This is established chemistry from cell and in vitro work, and it is a two-way interaction rather than a straightforward additive one.

Ubiquinol works in the lipid phase of membranes while glutathione works in the aqueous cytosol, and the two are linked through vitamin E and ascorbate recycling in the classical antioxidant network. Placing both means covering two compartments rather than one. The network chemistry is established; a combined effect in people has not been measured.

Unliganded ferrous iron reacts with hydrogen peroxide to generate hydroxyl radicals, and the resulting lipid peroxides are handled by glutathione peroxidase 4 using reduced glutathione. Higher labile iron therefore raises the demand on the glutathione pool. This is well-characterised redox chemistry and it is a caution to state, not a benefit to claim.

Copper cycles between its two oxidation states and is normally kept bound, in part by glutathione, which acts as an intracellular copper chaperone and buffer. Free copper both consumes glutathione and catalyses thiol oxidation. The interaction runs in both directions, which is why it is described here as modulating rather than additive.

Melatonin has been reported to raise expression of glutathione peroxidase and glutathione reductase in cell and animal systems, which are the enzymes that use and regenerate glutathione. Combining the two would put an enzyme-side and a substrate-side input together. The reports are preclinical, so the pairing is mechanistically plausible and clinically untested.

Resveratrol activates Nrf2-dependent transcription in cell systems, which includes the glutathione synthesis enzymes, and it also undergoes quinone chemistry that glutathione conjugates. Both effects have been shown in vitro at concentrations that human oral dosing struggles to reach. The direction is coherent but the evidence is preclinical.

In humans, cysteine is not strictly essential because methionine can supply it: the methionine sulfur passes through homocysteine and cystathionine to cysteine, which then limits glutathione synthesis. That makes methionine the upstream sulfur donor for the whole pool. Established biochemistry, and the reason sulfur amino acid intake and glutathione status are discussed together.